Judge Grills Amarin, FDA Over Off-Label Promo Statements
A New York federal judge on Tuesday appeared unlikely to immunize Amarin Pharma Inc. from punishment by the U.S. Food and Drug Administration for engaging in off-label promotion, while nonetheless suggesting...To view the full article, register now.
Already a subscriber? Click here to view full article